Kilitch Drugs (India) Limited - Laporan Laba Rugi (TTM)

Kilitch Drugs (India) Limited
IN ˙ NSEI
₹ 372.35 ↑10.85 (3.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Kilitch Drugs (India) Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 558 602 685 780 835 976 1,142 1,281 1,352 1,307 1,396 1,427 1,532 1,550 1,544 1,513 1,575 1,819 1,983 2,080
Change (%) 7.88 13.80 13.77 7.05 16.90 17.09 12.10 5.56 -3.30 6.78 2.22 7.36 1.19 -0.42 -2.01 4.15 15.47 9.02 4.89
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 317 327 379 411 461 570 674 746 785 712 754 716 771 804 794 805 853 1,011 1,053 1,115
Change (%) 3.21 15.81 8.35 12.27 23.55 18.27 10.71 5.29 -9.36 5.93 -5.05 7.62 4.34 -1.26 1.37 5.98 18.49 4.20 5.88
% of Revenue 56.83 54.37 55.33 52.69 55.26 58.40 58.99 58.26 58.10 54.46 54.02 50.18 50.30 51.87 51.43 53.21 54.14 55.56 53.10 53.61
Gross Operating Profit 241 275 306 369 373 406 468 535 566 595 642 711 761 746 750 708 722 808 930 965
Change (%) 14.02 11.41 20.48 1.25 8.69 15.44 14.11 5.95 5.10 7.81 10.77 7.10 -1.99 0.48 -5.59 2.06 11.90 15.05 3.75
% of Revenue 43.17 45.63 44.67 47.31 44.74 41.60 41.01 41.74 41.90 45.54 45.98 49.82 49.70 48.13 48.57 46.79 45.86 44.44 46.90 46.39
SG&A 91 89 97 110 126 132 117 133 154 178 232 238 240 243 240 252 281 299 313 331
Change (%) -2.31 9.68 12.64 15.39 4.69 -11.45 13.54 15.50 15.60 30.41 2.98 0.60 1.26 -1.36 5.17 11.53 6.53 4.43 5.79
% of Revenue 16.26 14.72 14.19 14.05 15.14 13.56 10.25 10.39 11.36 13.58 16.59 16.71 15.66 15.67 15.52 16.66 17.84 16.46 15.77 15.91
R&D
Change (%)
% of Revenue
OpEx 559 587 644 727 768 928 1,042 1,180 1,235 1,165 1,247 1,259 1,308 1,342 1,321 1,350 1,421 1,600 1,691 1,780
Change (%) 5.03 9.69 12.90 5.60 20.92 12.28 13.24 4.62 -5.63 7.05 0.92 3.91 2.61 -1.61 2.25 5.25 12.60 5.67 5.27
% of Revenue 100.13 97.49 93.97 93.25 91.99 95.15 91.23 92.16 91.34 89.14 89.36 88.22 85.39 86.58 85.56 89.27 90.22 87.98 85.28 85.59
Operating Income -1 15 41 53 67 47 100 100 117 142 149 168 224 208 223 162 154 219 292 300
Change (%) -2,177.34 173.37 27.33 27.07 -29.21 111.52 0.26 16.62 21.25 4.63 13.13 33.21 -7.09 7.20 -27.24 -5.07 41.97 33.53 2.64
% of Revenue -0.13 2.51 6.03 6.75 8.01 4.85 8.77 7.84 8.66 10.86 10.64 11.78 14.61 13.42 14.44 10.73 9.78 12.02 14.72 14.41
Interest Expense -9 -8 -8 -6 -5 -6 -12 -17 -34 -44 -49 -57 -55 -58 -59 -62 -50 -48 -50 -48
Change (%) -5.61 -8.36 -21.96 -9.39 21.32 85.20 45.39 93.48 31.25 11.17 16.83 -4.23 5.64 1.98 3.91 -19.53 -3.95 5.86 -4.00
% of Revenue -1.56 -1.37 -1.10 -0.76 -0.64 -0.66 -1.05 -1.36 -2.49 -3.38 -3.52 -4.03 -3.59 -3.75 -3.84 -4.07 -3.15 -2.62 -2.54 -2.33
Net Income 4 17 37 62 63 52 74 83 85 98 104 117 140 146 146 126 165 195 267 284
Change (%) 284.79 114.01 68.68 1.21 -17.39 42.29 12.20 3.28 14.59 6.80 12.16 19.74 3.84 0.21 -13.81 30.80 18.54 36.84 6.31
% of Revenue 0.80 2.85 5.36 7.94 7.51 5.31 6.45 6.45 6.31 7.48 7.48 8.21 9.16 9.40 9.46 8.32 10.45 10.73 13.46 13.65

Source: Capital IQ

Other Listings
IN:524500
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista